NewsRoom Articles - Page 22 of 208

FridayOct 04, 2024 11:15 am

Annovis Bio Inc. (NYSE: ANVS) Seeking to Strengthen Intellectual Property Portfolio, Protecting Multifaceted Approach for Treatment of Neurodegenerative Diseases

Annovis Bio recently filed three new patents covering combinations of buntanetap, its lead compound, with a GLP-1 agonist (such as dulaglutide/Trulicity) and with PDE5 inhibitors (such as sildenafil/Viagra), as well as a combination of all three The company believes these combinations create a broader approach to treating neurodegenerative diseases Preclinical studies have demonstrated these combinations significantly improve cognition in Alzheimer’s mouse models Combinations of buntanetap with PDE5 inhibitors and GLP-1 agonists are now ready to enter phase 3 clinical studies (buntanetap is in phase 3, and a number of PDE5 inhibitors and GLP-1 agonists are already on the market) Annovis…

FridayOct 04, 2024 10:00 am

Jimmy Carter Survival Thanks to Novel Cancer Immunotherapy Treatment

In August 2015, former president Jimmy Carter revealed at a conference held at the Carter Center that cancer had spread to his brain. Carter, then aged 91, discussed how his initial diagnosis of melanoma had led to the disease’s spread. If he had been diagnosed with the illness just a few years prior, he would have had about six months to live. Instead, the former president celebrated his 100th birthday on Oct. 1, 2024. While luck did play a role, experts believe Carter is alive today because of immunotherapy treatments. At the time, immunotherapy was a new treatment following the…

WednesdayOct 02, 2024 10:00 am

Disruptions in Purine Metabolism Cited in Parkinson’s Development

Parkinson’s disease is a neurodegenerative condition that affects an individual’s brain, causing issues with their movement, sleep and mental health. Common symptoms include tremors, slowed movements and issues with balance. For years, researchers have observed reduced uric acid levels in Parkinson’s disease patients. Uric acid is created when the human body breaks down purines, which are produced in the body. In the past, scientists posited that uric acid, which possesses antioxidant properties, played a role in decreasing oxidative stress in the brain. Now, new research has unveiled new insights into how patients with Parkinson’s disease suffer metabolic disruptions. Scientists began…

MondaySep 30, 2024 10:00 am

HRW Urges Governments to Fix Factors Fueling Healthcare Access Racial Inequalities

Earlier this week, Human Rights Watch called for governments to tackle racial inequalities and discrimination in healthcare. The international nongovernmental organization (NGO) discussed how prejudice and racism had impacted health rights globally. It also referred to General Recommendation No. 37 of the UN CERD, which discusses the elimination of all forms of racial discrimination regarding the right to health. While the NGO’s recommendation is nonbinding, it touches on different initiatives governments can employ to address discrimination and racial inequalities in healthcare. These initiatives include the promotion of healthy working conditions, addressing environmental issues, and making sure individuals have access to…

FridaySep 27, 2024 10:00 am

Addressing Vision Problems Could Lower Risk of Dementia, Study Finds

New research suggests that addressing any issues with your vision may reduce your risk of future brain issues. The research was led by Jason Smith, an epidemiologist at the Bloomberg School of Public Health at Johns Hopkins. For their research, the investigators analyzed data from more than 2,700 patients in the United States. They discovered that roughly 19% of cases of dementia could be linked to a vision issue. This included loss in near visual acuity and loss of sensitivity in detecting contrast. They also found that the link between dementia and vision was almost nine times higher when contrast…

WednesdaySep 25, 2024 10:00 am

Whooping Cough Prevalence Rises in US as Missed Shots During Pandemic Come Home to Roost

New figures released by the CDC show that whooping cough cases have increased significantly in the United States since 2023. The rise in cases has been attributed to a reduction in rates of vaccination, which started during the pandemic. Whooping cough, also referred to as pertussis, is an infection that affects the respiratory tract. This illness is especially dangerous for infants and is highly contagious. An infectious diseases expert, Dr. William Schaffner, explains that these debilitating cough seizures are normally caused by irritation in the mucus membranes, which makes it hard for an individual to breathe. Babies may not cough,…

WednesdaySep 25, 2024 9:00 am

Annovis Bio Inc. (NYSE: ANVS) Presented Recent Achievements and Strategic Direction at H.C. Wainwright Investment Conference

The event was attended by Annovis Founder, President and CEO Maria L. Maccecchini, Ph.D. Dr. Maccecchini discussed the company’s notable achievements and plans for the future and held a Q&A session with attendees. The company CEO also participated in an expert panel discussing innovative non-amyloid approaches in Alzheimer’s disease. Recent clinical trials of the company’s lead compound buntanetap obtained encouraging results and was shown to improve cognition in both Alzheimer’s and Parkinson’s patients. Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), participated in…

TuesdaySep 24, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) to Discuss Lead Candidate CNM-Au8(R) Biomarker, Clinical Data for ALS with Food and Drug Administration Leadership

The company is seeking an accelerated approval regulatory pathway for CNM-Au8® for ALS. The FDA agreed to an in-person meeting to reevaluate Clene’s submission. Lead drug candidate CNM-Au8 has been shown to restore and protect neurological function, offering hope for patients with neurodegenerative conditions. The FDA meeting will be held before the end of November and will be attended by top FDA officials and key opinion leaders in ALS, biostatistics and biomarkers. Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including…

MondaySep 23, 2024 10:00 am

Study Links Iron Deficiency to Disturbed Sleep Among Autism, ADHD Patients

Sleep disorders are often caused by hypermotor restlessness, restless leg syndrome, hyperarousability, periodic limb movements in sleep and restless sleep disorder. Now, a new study has considered the role iron levels play in causing these disorders. Iron is usually found in microglia, oligodendrocytes, astrocytes and neurons. This element is needed to help synthesize neurotransmitters that regulate the wake/sleep cycle. The study used data gathered from structured intake forms and clinical evaluations conducted at the Child & Adolescent Psychiatry division of the Sleep/Wake-Behavior clinic in BC Children’s Hospital. Data on parental history of iron deficiency, recent iron status and covariate factors…

FridaySep 20, 2024 10:00 am

Women Reach Settlement After Yale Nurse Switched Painkillers with Saline Solution

Last week, a group of women who experienced severe pain at a fertility clinic at Yale University after they received saline instead of a painkiller had their suits against the Ivy League school settled. This settlement comes after seven women sued the institution in 2021. Soon after, more patients filed lawsuits, which brought the number of plaintiffs to more than 150. Most of them claimed that because of their experience at the clinic, they suffered from post-traumatic stress disorder (PTSD). One of the plaintiffs, Soryorelis Henry, stated that the experience, which should have been joyous and hopeful, became traumatic. Collectively,…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Annovis Bio Inc. (NYSE: ANVS) Seeking to Strengthen Intellectual Property Portfolio, Protecting Multifaceted Approach for Treatment of Neurodegenerative Diseases

Jimmy Carter Survival Thanks to Novel Cancer Immunotherapy Treatment

Disruptions in Purine Metabolism Cited in Parkinson’s Development

HRW Urges Governments to Fix Factors Fueling Healthcare Access Racial Inequalities

Addressing Vision Problems Could Lower Risk of Dementia, Study Finds

Whooping Cough Prevalence Rises in US as Missed Shots During Pandemic Come Home to Roost

Annovis Bio Inc. (NYSE: ANVS) Presented Recent Achievements and Strategic Direction at H.C. Wainwright Investment Conference

Clene Inc. (NASDAQ: CLNN) to Discuss Lead Candidate CNM-Au8(R) Biomarker, Clinical Data for ALS with Food and Drug Administration Leadership

Study Links Iron Deficiency to Disturbed Sleep Among Autism, ADHD Patients

Women Reach Settlement After Yale Nurse Switched Painkillers with Saline Solution

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search